⌘K

Login Start Free

Home/Filings/4/0001209191-20-002064

4//SEC Filing

Morich Frank 4

Accession 0001209191-20-002064

CIK 0001645460other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 6:01 PM ET

Size

5.3 KB

Accession

0001209191-20-002064

Insider Transaction Report

Form 4

Period: 2020-01-02

Cue Biopharma, Inc.CUE

Director

Transactions

Award
Stock Option (right to buy)
2020-01-02+8,000→ 8,000 total
Exercise: $16.31From: 2021-01-02Exp: 2030-01-02→ Common Stock (8,000 underlying)

Footnotes (1)

[F1]Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cue Biopharma, Inc.

CIK 0001645460

Entity typeother

Related Parties

1

filerCIK 0001748615

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 6:01 PM ET
Size: 5.3 KB

View on SEC.gov